Estrogenic effect of soy isoflavones on mammary gland morphogenesis and gene expression profile

Anni Rønfeldt Thomsen, Kristian Almstrup, John E Nielsen, Ilona Kryspin Sørensen, Ole William Petersen, Henrik Leffers, Vibeke M Breinholt

22 Citationer (Scopus)


We examined the effect of 17beta-estradiol (E2) and soy isoflavones' exposure on morphogenesis and global gene expression in the murine mammary gland. Three exposure regimens were applied: isoflavones added to the diet throughout either the lactational period (via the dams) or the postweaning period and E2 administered orally during the lactational period. Whole mounts of mammary glands were evaluated both in juvenile and adult animals with respect to branching morphogenesis and terminal end bud (TEB) formation. At postnatal day (PND) 28, we observed a significant increase in branching morphogenesis in all treated groups with the most pronounced effect after E2 exposure. For the E2-treated animals there was also a significant increase in TEB formation. At PNDs 42-43 the postweaning isoflavone and the E2 groups showed a transient reduction in the number of TEBs. A similar response after isoflavone and E2 exposure was further substantiated by changes in gene expression, since the same groups of genes were up- and downregulated, particularly in the E2 and postweaning isoflavone regimen. All changes in gene expression correlated with changes in the cellular composition of the gland, i.e., more and larger TEBs and ducts. The results suggest an estrogenic response of physiological doses of isoflavones on mammary gland development at both the morphological and molecular level, which resembled that induced by puberty.
TidsskriftToxicological Sciences
Udgave nummer2
Sider (fra-til)357-68
Antal sider12
StatusUdgivet - okt. 2006


Dyk ned i forskningsemnerne om 'Estrogenic effect of soy isoflavones on mammary gland morphogenesis and gene expression profile'. Sammen danner de et unikt fingeraftryk.